Viral Vector and Plasmid DNA Manufacturing Market
Viral Vector and Plasmid DNA Manufacturing Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Type Plasmid DNA, Viral Vector, Non-viral Vector
- By Application Cancer, Genetic Disorder, Infectious Disease, Other Applications
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 697.16 Million |
Revenue 2030: | USD 2285.58 Million |
Revenue CAGR (2023 - 2030): | 16.00% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Viral Vector and Plasmid DNA Manufacturing Market - Segment Analysis
- Overview
- Global Viral Vector and Plasmid DNA Manufacturing Market, 2016 - 2028 (USD Million)
-
Global Viral Vector and Plasmid DNA Manufacturing Market - by Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
-
Global Viral Vector and Plasmid DNA Manufacturing Market - by Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
-
Global Viral Vector and Plasmid DNA Manufacturing Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Viral Vector and Plasmid DNA Manufacturing Market - Segment Analysis
- Overview
- North America Viral Vector and Plasmid DNA Manufacturing Market, 2016 - 2028 (USD Million)
-
North America Viral Vector and Plasmid DNA Manufacturing Market, by Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
-
North America Viral Vector and Plasmid DNA Manufacturing Market, by Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
-
North America Viral Vector and Plasmid DNA Manufacturing Market, by Country
- U.S.
- U.S. Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- U.S. Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- U.S. Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Canada
- Canada Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Canada Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Canada Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Mexico
- Mexico Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Mexico Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Mexico Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- U.S.
-
Europe Viral Vector and Plasmid DNA Manufacturing Market - Segment Analysis
- Overview
- Europe Viral Vector and Plasmid DNA Manufacturing Market, 2016 - 2028 (USD Million)
-
Europe Viral Vector and Plasmid DNA Manufacturing Market, by Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
-
Europe Viral Vector and Plasmid DNA Manufacturing Market, by Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
-
Europe Viral Vector and Plasmid DNA Manufacturing Market, by Country
- Germany
- Germany Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Germany Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Germany Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- UK
- UK Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- UK Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- UK Market, By Product Type
- France
- France Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- France Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- France Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Spain
- Spain Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Spain Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Spain Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Italy
- Italy Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Italy Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Italy Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- BENELUX
- BENELUX Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- BENELUX Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- BENELUX Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Rest of Europe
- Rest Of Europe Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Rest Of Europe Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Rest Of Europe Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Germany
-
Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market - Segment Analysis
- Overview
- Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, 2016 - 2028 (USD Million)
-
Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, by Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
-
Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, by Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
-
Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, by Country
- China
- China Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- China Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- China Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Japan
- Japan Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Japan Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Japan Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- India
- India Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- India Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- India Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- South Korea
- South Korea Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- South Korea Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- South Korea Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- South East Asia
- South East Asia Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- South East Asia Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- South East Asia Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Rest of Asia Pacific
- Rest of Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Rest of Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Rest of Asia Pacific Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- China
-
Latin America Viral Vector and Plasmid DNA Manufacturing Market - Segment Analysis
- Overview
- Latin America Viral Vector and Plasmid DNA Manufacturing Market, 2016 - 2028 (USD Million)
-
Latin America Viral Vector and Plasmid DNA Manufacturing Market, by Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
-
Latin America Viral Vector and Plasmid DNA Manufacturing Market, by Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
-
Latin America Viral Vector and Plasmid DNA Manufacturing Market, by Country
- Brazil
- Brazil Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Brazil Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Brazil Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Argentina
- Argentina Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Argentina Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Argentina Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Rest of Latin America
- Rest of Latin America Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Rest of Latin America Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Rest of Latin America Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Brazil
-
Middle East & Africa Viral Vector and Plasmid DNA Manufacturing Market - Segment Analysis
- Overview
- Middle East & Africa Viral Vector and Plasmid DNA Manufacturing Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Viral Vector and Plasmid DNA Manufacturing Market, by Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
-
Middle East & Africa Viral Vector and Plasmid DNA Manufacturing Market, by Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
-
Middle East & Africa Viral Vector and Plasmid DNA Manufacturing Market, by Country
- GCC Countries
- GCC Countries Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- GCC Countries Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- GCC Countries Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- South Africa
- South Africa Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- South Africa Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- South Africa Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- Rest of Middle East & Africa
- Rest of Middle East & Africa Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- By Plasmid DNA
- By Viral Vector
- By Non-viral Vector
- Rest of Middle East & Africa Viral Vector and Plasmid DNA Manufacturing Market, By Application
- By Cancer
- By Genetic Disorder
- By Infectious Disease
- By Other Applications
- Rest of Middle East & Africa Viral Vector and Plasmid DNA Manufacturing Market, By Product Type
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Fujifilm Diosynth Biotechnologies (US)
- SIRION Biotech (Germany)
- Thermo Fisher Scientific (US)
- Merck KGaA Inc. (US)
- Cognate BioServices Inc. (Cobra Biologics) (US)​ are the major companies operating in Global Viral Vector and Plasmid DNA Manufacturing Market.
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Viral Vector and Plasmid DNA Manufacturing in terms of revenue?
-
The global Viral Vector and Plasmid DNA Manufacturing valued at USD 697.16 Million in 2022 and is expected to reach USD 2285.58 Million in 2030 growing at a CAGR of 16.00%.
Which are the prominent players in the market?
-
The prominent players in the market are Fujifilm Diosynth Biotechnologies (US), SIRION Biotech (Germany), Thermo Fisher Scientific (US), Merck KGaA Inc. (US), Cognate BioServices Inc. (Cobra Biologics) (US)​ are the major companies operating in Global Viral Vector and Plasmid DNA Manufacturing Market..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 16.00% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Viral Vector and Plasmid DNA Manufacturing include
- Rising R&D Funding and Growing Initiatives
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Viral Vector and Plasmid DNA Manufacturing in 2022.